S49 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Supernus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 37.8 EUR -14.48%

Market Cap: €2.1B

S	Supernus Pharmaceuticals Inc SWB:S49	US
	Bubs Australia Ltd OTC:BUBSF	AU

Profitability Summary

Supernus Pharmaceuticals Inc's profitability score is 41/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

86% > 88%

Negative Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

5% > 0%

Negative Net Margin

-13%

Low 3Y Average Net Margin

Declining Net Margin

4% > -13%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

17%

Declining Free Cash Flow Margin

View All

Hide

Collapse

41 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.